drugset / Trial / NCT03035734
Evaluate the Bioavailability Between 2 BMS-986141 Formulations in Healthy Participants
RandomizedCrossoverOpen-labelTreatment
Summary
Open label, randomized, 4-period crossover study with single doses of BMS-986141 given to healthy female subjects of non-childbearing potential and healthy males.
Timeline
- Start
- 2017-01-25
- Primary completion
- 2017-02-07
- Completion
- 2017-02-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986141 | Small molecule | — | Oral |
Indications
No indication recorded.